mTOR inhibitor treatment in patients with tuberous sclerosis complex is associated with specific changes in microRNA serum profile.
Authors: Bartłomiej Pawlika, Urszula Smyczyńska, Szymon Grabia, Wojciech Fendler, Izabela Dróżdż, Katarzyna Bąbol-Pokora, Katarzyna Kotulska, Sergiusz Jóźwiak, Julita Borkowska, Wojciech Młynarski, Joanna Trelińska
Published in: Journal of Clinical Medicine
Publication type: article
Subject areas: Medicine
SJR best quartile: Q1